期刊文献+

冠心病心绞痛患者血细胞参数的多因素Logistic分析

The logistic analysis of blood cell parameter in coronary heart disease angina patients
下载PDF
导出
摘要 目的探讨冠心病患者外周血血细胞参数的临床意义。方法选择101例经冠状动脉造影证实的冠心病心绞痛(CHD)患者,其中稳定性心绞痛(SAP)35例,不稳定心绞痛(ACS)56例,陈旧性心梗10例,男77名,女24名,年龄57.56±8.30岁,同期行冠状动脉造影阴性患者78例做为对照组,男38名,女40名;年龄55.30±7.65岁。用GENS血细胞计数仪分别测定外周血白细胞计数、单核细胞绝对值、红细胞计数、血红蛋白、血小板计数等。结果两组患者的年龄、血脂、高血压史、糖病史等指标均无差异(P>0.05);CHD组的男性患者、吸烟者、血红蛋白及单核细胞绝对值显著高于对照组(P<0.05)。结论冠心病组与对照组进行Logistic多因素回归分析,结果冠心病心绞痛与年龄、高密度脂蛋白、总胆固醇、单核细胞绝对值及血红蛋白具有相关性。 Objective To explore the clinical significance of peripheral blood cell parameter in coronary heart disease(CHD)patients. Methods We chose one hundred and one CHD patients that had proved by coronary artery visualization, 35 with stable angina, 56 with unstable angina, and 10 with old heart infarction,men77, women24,aged57.56±8.30; in the same time we chose sevanty-eight patients as the control group, whic h had negative outcome in coronary artery visualization,men38,woman40, aged55.30±7.65.we detected the blood cell count, mononuclear cells a bsolnte value, red blood count, hentoglobin,blood platelets count and so on by GENS. Results There were no significantly difference in age, blood fat, history of high blood pressure and blood glucose in two groups(P〉0.05); The patients in CHD group were significantly higher than that of in control group in man, sraoker, the value of hemoglobin and mononuclear cells absolute value were higher too(P〈0.05). Conclusion The logistic multiple factor regression analysis analysis showed that there were correlation between the coronary heart disease angina and age, high density lipoprotein, total cholesterol, hemoglobin and mononuclear cells absolute value in two groups.
出处 《疾病监测与控制》 2011年第10期601-602,597,共3页 Journal of Diseases Monitor and Control
关键词 动脉粥样硬化性心脏病 危险因素 血细胞参数 atherosclerotic heart disease (AHD): risk factor: blood cell parameter
  • 相关文献

参考文献9

  • 1潘柏申.应重视心脏标志物的临床应用研究[J].中华检验医学杂志,2005,28(9):881-884. 被引量:56
  • 2Fred SA,Alan HW, Mair J,et al.Future biomarkers for detection of ischemaand Risk Stratification in Acute co ronarysyndrom[J]. ClincalChemistry,2005,51:810-824.
  • 3Buffon A,Biasucci LM,Liuzzo G, et al.Wide spread coronary, inflammationin Unstable angina[J].NEng J Med,2002,347:5-12.
  • 4徐也鲁.动脉粥样硬化——一种慢性炎症过程[J].中国动脉硬化杂志,2001,9(2):93-95. 被引量:187
  • 5Takasi Hasegawa,Toyoko Negishi,Miyako Deguchi.WBC count, atherosclerosis andCoronary risk factors[J].J Atjeroscler Thromb, 2002,(9):219-223.
  • 6Ho jo Y, Ikeda U,Takahashim,et al.lnerersed Levels ofmonocyte2 re21ated Cytokines in patientswith unstable angina[J].Atheroscl erosis,2002,161 (2).
  • 7Oleksowicz L,Mrowiex Z,Issacs R,et al.Morphollgic and ultrastr uc2tural evidence for interleukin26 induced p latelet activation [J].Am JHematol, 1995,48(2):92-99.
  • 8Johnny N,AndersW, Andrea T, et al.Circulating levels of p roinfla m2matory cytokines and neutrophil2p latelet aggreagates in patients withcoronary artery disease[J].Am J Cardion,2005,95(4): 452-456.
  • 9ManginasA Bei E,Chaidaroglou A,et al.Peripheral levels of matr ixmetallop roteinase29, interleukin26,and C2reactive protein are elev atedin patientswith acute coronary syndromes:correlationswi th serum tro2ponin I[J].Clin Cardiol,2005,28(4):182-186.

二级参考文献12

  • 1Yu H,Biochemistry,2000年,33卷,8期,601页
  • 2The Joint European Society of Cardiology/American College Cardiology Committee. Myocardial infarction redefined -- A consensus document of the Joint European Society of Cardiology/American College Cardiology Committee for the redefinition of myocardial infarction.J Am Coll Cardial,2000,36:959-969.
  • 3Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction:Executive summary and recommendations.Circulation,2000,102:1193-1209.
  • 4Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA 2002 Guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. http://www.acc.org/clinical/guidelines/unstable/incorporated/UA_incorporated.
  • 5National Institute of Standards and Technology.Certificate of analysis.Standard reference material 2921-human cardiac troponin complex.Gaithersburg (MD):NIST;2004.
  • 6Panteghini M,Forest JC.Standardization in laboratory medicine:New challenges.Clin Chim Acta,2005,355:1-12.
  • 7Wu AHB,Apple FS,Gibler WB,et al.National Academy of Clinical Biochemistry standards of laboratory practice:Recommendations for the use of cardiac markers in coronary artery diseases.Clin Chem,1999,45:1104-1121.
  • 8Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease.AHA and CDC Scientific Statement.Circulation,2003, 107:499-511.
  • 9Morrow DA,Braunwald E.Future of biomarkers in acute coronary syndromes:moving toward amultimarker strategy.Circulation,2003,108:250-252.
  • 10Panteghini M,Apple FS,Christenson RH,et al.IFCC Scientific Division.Committee on Standardization of Markers of Cardiac Damage.Use of biochemical markers in acute coronary syndromes.Clin Chem Lab Med,1999,37:687-893.

共引文献240

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部